Professional
Added to YB: 2024-03-15
Pitch date: 2024-01-11
HROW [bullish]
Harrow, Inc.
+252.75%
current return
Author Info
No bio for this author
Upgrade to Yellowbrick Premium to unlock investor returns. Upgrade to Yellowbrick Premium
Company Info
Harrow, Inc., an eyecare pharmaceutical company, engages in the discovery, development, and commercialization of ophthalmic pharmaceutical products in the United States.
Market Cap
$1.3B
Pitch Price
$10.01
Price Target
N/A
Dividend
N/A
EV/EBITDA
29.74
P/E
-253.44
EV/Sales
5.49
Sector
Pharmaceuticals
Category
turnaround
Show full summary:
Wasatch Micro Cap Value Strategy Porfolio Holding: Harrow, Inc. - $HROW
HROW: Ophthalmic pharma co. focused on dry eye, glaucoma, etc. Lowered guidance in Nov, stock down big. Holding small position, expecting turnaround in next 2 qtrs at current cheap valuation.
Read full article (1 min)